Tomas Jernberg

20.6k total citations · 7 hit papers
331 papers, 11.7k citations indexed

About

Tomas Jernberg is a scholar working on Cardiology and Cardiovascular Medicine, Radiology, Nuclear Medicine and Imaging and Surgery. According to data from OpenAlex, Tomas Jernberg has authored 331 papers receiving a total of 11.7k indexed citations (citations by other indexed papers that have themselves been cited), including 268 papers in Cardiology and Cardiovascular Medicine, 96 papers in Radiology, Nuclear Medicine and Imaging and 75 papers in Surgery. Recurrent topics in Tomas Jernberg's work include Acute Myocardial Infarction Research (171 papers), Cardiac Imaging and Diagnostics (96 papers) and Heart Failure Treatment and Management (67 papers). Tomas Jernberg is often cited by papers focused on Acute Myocardial Infarction Research (171 papers), Cardiac Imaging and Diagnostics (96 papers) and Heart Failure Treatment and Management (67 papers). Tomas Jernberg collaborates with scholars based in Sweden, United Kingdom and United States. Tomas Jernberg's co-authors include Bertil Lindahl, Lars Wallentin, Stefan James, Karolina Szummer, David Erlinge, Stefan Agewall, Per Venge, Kai M. Eggers, Tomasz Baron and Mats Stridsberg and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

Tomas Jernberg

306 papers receiving 11.5k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cardiovascular risk in post-myocardial infarction patients: nationwide real world data demonstrate the importance of a long-term perspective

2015 594 citations Tomas Jernberg, Pål Hasvold et al. European Heart Journal profile →
The Swedish Web-system for Enhancement and Development of Evidence-based care in Heart disease Evaluated According to Recommended Therapies (SWEDEHEART)

2010 570 citations Tomas Jernberg, Kristina Hambræus et al. Heart profile →
Troponin elevation in coronary vs. non-coronary disease

2010 456 citations Stefan Agewall, Tomas Jernberg et al. European Heart Journal profile →
Medical Therapy for Secondary Prevention and Long-Term Outcome in Patients With Myocardial Infarction With Nonobstructive Coronary Artery Disease

2017 309 citations Bertil Lindahl, Tomasz Baron et al. Circulation profile →
Improved outcomes in patients with ST-elevation myocardial infarction during the last 20 years are related to implementation of evidence-based treatments: experiences from the SWEDEHEART registry 1995–2014

2017 276 citations Karolina Szummer, Lars Wallentin et al. European Heart Journal profile →
Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction

2024 99 citations Troels Yndigegn, Bertil Lindahl et al. profile →
Early Ezetimibe Initiation After Myocardial Infarction Protects Against Later Cardiovascular Outcomes in the SWEDEHEART Registry

2025 14 citations Margrét Leósdóttir, Jessica Schubert et al. Journal of the American College of Cardiology profile →

Peers

Countries citing papers authored by Tomas Jernberg

Since Specialization

Citations

This map shows the geographic impact of Tomas Jernberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomas Jernberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomas Jernberg more than expected).

Fields of papers citing papers by Tomas Jernberg

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tomas Jernberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomas Jernberg. The network helps show where Tomas Jernberg may publish in the future.

Co-authorship network of co-authors of Tomas Jernberg

This figure shows the co-authorship network connecting the top 25 collaborators of Tomas Jernberg. A scholar is included among the top collaborators of Tomas Jernberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomas Jernberg. Tomas Jernberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Title	Journal	Authors	Indexed citations
1	The prognostic value of global longitudinal strain in patients with myocardial infarction and preserved ejection fraction: a prespecified substudy of the REDUCE-AMI trial	European Heart Journal - Cardiovascular Imaging	Robin Hofmann, Martin Jönsson et al.	1
2	Short-Term Effects of Lower Air Temperature and Cold Spells on Myocardial Infarction Hospitalizations in Sweden	Journal of the American College of Cardiology	Wenli Ni, Massimo Stafoggia et al.	5
3	Importance of hospital and clinical factors for early mortality in Takotsubo syndrome: Insights from the Swedish Coronary Angiography and Angioplasty Registry	BMC Cardiovascular Disorders	Björn Redfors, Truls Råmunddal et al.	0
4	Percutaneous vs. surgical revascularization of non-ST-segment elevation myocardial infarction with multivessel disease: the SWEDEHEART registry	European Heart Journal	Elmir Ömerovic, Truls Råmunddal et al.	7
5	Lower income is associated with non-persistence to statin treatment after a first myocardial infarction	European Heart Journal	Kun Ma, Tomas Jernberg et al.	1
6	Abbreviated versus standard dual antiplatelet therapy time after PCI in high bleeding risk patients with acute coronary syndrome - a report from the SWEDEHEART registry	European Heart Journal	Sasha Koul, Elmir Ömerovic et al.	1
7	Design and rationale of randomized evaluation of decreased usage of beta-blockers after acute myocardial infarction (REDUCE-AMI)	European Heart Journal - Cardiovascular Pharmacotherapy	Troels Yndigegn, Bertil Lindahl et al.	15
8	Comparing Effect Estimates in Randomized Trials and Observational Studies From the Same Population: An Application to Percutaneous Coronary Intervention	Journal of the American Heart Association	Anthony Matthews, Karolina Szummer et al.	18
9	Incidence, associated outcomes, and predictors of upper gastrointestinal bleeding following acute myocardial infarction: a SWEDEHEART-based nationwide cohort study	European Heart Journal - Cardiovascular Pharmacotherapy	Tomas Jernberg, Magnus Bäck et al.	30
10	The SWEDEHEART secondary prevention and cardiac rehabilitation registry (SWEDEHEART CR registry)	European Heart Journal - Quality of Care and Clinical Outcomes	Maria Bäck, Margrét Leósdóttir et al.	36
11	Randomized comparison of early supplemental oxygen versus ambient air in patients with confirmed myocardial infarction: Sex-related outcomes from DETO2X-AMI	American Heart Journal	Joakim Alfredsson, Stefan James et al.	2
12	Myocardial infarction in diffuse large B‐cell lymphoma patients – a population‐based matched cohort study	Journal of Internal Medicine	Sara Ekberg, Tomas Jernberg et al.	10
13	Helicobacter pylori screening in clinical routine during hospitalization for acute myocardial infarction	American Heart Journal	Sven‐Christian Pawelzik, David Erlinge et al.	18
14	Association between β-blocker dose and cardiovascular outcomes after myocardial infarction: insights from the SWEDEHEART registry	European Heart Journal Acute Cardiovascular Care	John Wallert, Claes Held et al.	14
15	Use of proteomics to identify biomarkers associated with chronic kidney disease and long‐term outcomes in patients with myocardial infarction	Journal of Internal Medicine	Robert Edfors, Lars Lindhagen et al.	8
16	Low-density lipoprotein cholesterol reduction and statin intensity in myocardial infarction patients and major adverse outcomes: a Swedish nationwide cohort study	European Heart Journal	Jessica Schubert, Bertil Lindahl et al.	109
17	Oxygen Therapy in Myocardial Infarction Patients With or Without Diabetes: A Predefined Subgroup Analysis From the DETO2X-AMI Trial	Diabetes Care	Thomas Nyström, Stefan James et al.	5
18	Outcomes in patients treated with ticagrelor versus clopidogrel after acute myocardial infarction stratified by renal function	Heart	Robert Edfors, Anders Sahlén et al.	27
19	Medical Therapy for Secondary Prevention and Long-Term Outcome in Patients With Myocardial Infarction With Nonobstructive Coronary Artery Disease breakdown →	Circulation	Bertil Lindahl, Tomasz Baron et al.	309
20	Abstract 13206: Culprit and Non-Culprit Recurrent Ischemic Events in Post-Myocardial Infarction Patients: Data From SWEDEHEART	Circulation	Christoph Varenhorst, Saga Johansson et al.	0

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact